Cargando…
Cardiovascular events in hyperuricemia population and a cardiovascular benefit-risk assessment of urate-lowering therapies: a systematic review and meta-analysis
BACKGROUND: Hyperuricemia and gout have become public health concerns; many important guidelines have recommended xanthine oxidase inhibitors (XOIs) as the first-line urate-lowering therapies (ULTs) to treat chronic gout with hyperuricemia. However, whether treating hyperuricemia and gout with ULTs...
Autores principales: | Zhao, Li, Cao, Ling, Zhao, Tian-Yi, Yang, Xue, Zhu, Xiao-Xia, Zou, He-Jian, Wan, Wei-Guo, Xue, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176444/ https://www.ncbi.nlm.nih.gov/pubmed/32106120 http://dx.doi.org/10.1097/CM9.0000000000000682 |
Ejemplares similares
-
Hyperuricemia, urate-lowering therapy, and kidney outcomes: a systematic review and meta-analysis
por: Sharma, Gaurav, et al.
Publicado: (2021) -
Association of COPD exacerbations and acute cardiovascular events: a
systematic review and meta-analysis
por: Müllerová, Hana, et al.
Publicado: (2022) -
Relationships of OPG Genetic Polymorphisms with Susceptibility to Cardiovascular Disease: A Meta-Analysis
por: Song, De-Hua, et al.
Publicado: (2016) -
Association between air pollution and cardiovascular mortality in China: a systematic review and meta-analysis
por: Zhao, Lei, et al.
Publicado: (2017) -
Cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors: A meta-analysis of cardiovascular outcome trials
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2021)